Status:
COMPLETED
Coronary Heart Disease Risk in Type 2 Diabetes
Lead Sponsor:
City, University of London
Collaborating Sponsors:
University College, London
Conditions:
Coronary Heart Disease
Type 2 Diabetes
Eligibility:
All Genders
25-74 years
Phase:
NA
Brief Summary
The primary objective of the CORDIA study is to use an effective evidence-based self-management intervention (SMI) for type 2 diabetes, with and without a novel test to give a personalised genetic and...
Eligibility Criteria
Inclusion
- Males and females aged 25-70 years diagnosed with type 2 diabetes
- White, Afro-Caribbean or Asian-Indian ethnicity
- Most previous or baseline HbA1c ≥6.5% or 48 mmol/mol
- Fluency in written and spoken English
Exclusion
- Diagnosis of ischemic heart disease, stroke, Transient Ischaemic Attack (TIA) or peripheral vascular disease
- Serious or enduring mental health problems that would prevent the patient from completing the study
- Currently receiving treatment for a life-threatening condition (e.g., cancer) or in the terminal stages of a condition
- Adults who cannot consent for themselves
Key Trial Info
Start Date :
July 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2016
Estimated Enrollment :
211 Patients enrolled
Trial Details
Trial ID
NCT01891786
Start Date
July 1 2013
End Date
June 1 2016
Last Update
August 4 2016
Active Locations (10)
Enter a location and click search to find clinical trials sorted by distance.
1
Addison House Surgery
Harlow, Essex, United Kingdom, CM20 1DS
2
Church Street Surgery
Ware, Essex, United Kingdom, SG12 9EG
3
Dolphin House Surgery
Ware, Essex, United Kingdom, SG12 9HJ
4
Wallace House Surgery
Hertford, Hertfordshire, United Kingdom, SG14 1HZ